| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Total Income - EUR | 4.811 | 3.878 | 2.533 | 840 | 784 | - | - | - | - | - |
| Total Expenses - EUR | 16.427 | 12.493 | 5.149 | 3.396 | 184 | - | - | - | - | - |
| Gross Profit/Loss - EUR | -11.616 | -8.616 | -2.616 | -2.557 | 600 | - | - | - | - | - |
| Net Profit/Loss - EUR | -11.616 | -8.616 | -8.009 | -2.557 | 600 | - | - | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
Check the financial reports for the company - Royal Med Rx Energy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Current Assets | 53.778 | 53.323 | 53.077 | 52.090 | 51.708 | - | - | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Receivables | 53.762 | 53.306 | 53.053 | 52.102 | 51.701 | - | - | - | - | - |
| Cash | 17 | 17 | 24 | -12 | 7 | - | - | - | - | - |
| Shareholders Funds | -81.818 | -89.599 | -96.092 | -96.885 | -94.409 | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | - | - | - | - |
| Debts | 135.596 | 142.922 | 149.169 | 148.975 | 146.117 | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4651 - 4651" | |||||||||
| CAEN Financial Year |
4651
|
|||||||||
Comments - Royal Med Rx Energy S.r.l.